Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland

NCT01630226 is registered in ClinicalTrials.gov with Pomeranian Medical University Szczecin as lead sponsor.

NCT NCT01630226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01630226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cisplatin-monotherapy in the Treatment of BRCA1 Positive Breast Cancer Patients in Poland
Lead sponsor
Pomeranian Medical University Szczecin
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2007
Completion date
Not reported
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca1 mutation, breast cancer invasive nos